Ying Taur

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc Microbiome mediation of infections in the cancer setting
    Ying Taur
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA
    Genome Med 8:40. 2016
  2. pmc The intestinal microbiota and susceptibility to infection in immunocompromised patients
    Ying Taur
    Infectious Diseases, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, New York 10065, USA
    Curr Opin Infect Dis 26:332-7. 2013
  3. pmc Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 55:905-14. 2012
  4. pmc Effect of antifungal therapy timing on mortality in cancer patients with candidemia
    Ying Taur
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 9, New York, NY 10065, USA
    Antimicrob Agents Chemother 54:184-90. 2010
  5. pmc The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, and Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY Weill Cornell Medical College, New York, NY
    Blood 124:1174-82. 2014
  6. pmc Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation
    Melissa A Kinnebrew
    Immunology Program, Sloan Kettering Institute, New York, New York, United States of America Weill Cornell Medical College, New York, New York, United States of America
    PLoS ONE 9:e90158. 2014
  7. pmc Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
    Robert R Jenq
    Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:903-11. 2012
  8. pmc Role of intestinal microbiota in transplantation outcomes
    Ying Taur
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Weill Cornell Medical College, New York
    Best Pract Res Clin Haematol 28:155-61. 2015
  9. pmc Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
    Charlie G Buffie
    1 Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA 2 Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Nature 517:205-8. 2015
  10. pmc Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 81:965-73. 2013

Collaborators

  • Carles Ubeda
  • Susan K Seo
  • Marcel van den Brink
  • Joao B Xavier
  • Mini Kamboj
  • Juliet N Barker
  • Anna Kaltsas
  • Sergio A Giralt
  • Susan E Prockop
  • Vanni Bucci
  • Hui Liu
  • Trudy N Small
  • Robert R Jenq
  • Eric G Pamer
  • Lilan Ling
  • Asia Gobourne
  • Sejal Morjaria
  • Simone Becattini
  • Miguel Angel Perales
  • John R Lee
  • Charlie G Buffie
  • Nora C Toussaint
  • Justin R Cross
  • Daniel No
  • Eric R Littmann
  • Melissa A Kinnebrew
  • Jarrod A Dudakov
  • Alan M Hanash
  • Jenna D Goldberg
  • Tarek Mikati
  • Lauren Lipuma
  • Michelle B Mahler
  • David J Epstein
  • Marc Rosenblum
  • Michael Scordo
  • Vaios Hatzoglou
  • Fabian A Romero
  • Genovefa A Papanicolaou
  • Nicholas Arpaia
  • Asia C Gobourne
  • Peter T McKenney
  • Manikkam Suthanthiran
  • Chris Sander
  • Liza C Miller
  • Katya F Ahr
  • Hendrik Poeck
  • Jonathan U Peled
  • Melissa A Lumish
  • Richard R Stein
  • Yusuke Shono
  • Melissa D Docampo
  • Melissa Kinnebrew
  • Eric Pamer
  • Thangamani Muthukumar
  • Doris M Ponce
  • Sean M Devlin
  • Agnes Viale
  • Darshana Dadhania
  • Tatanisha K Peets
  • Eric Littmann
  • Yeon Joo Lee
  • Monika K Shah
  • Raya Khanin
  • Lauren F Young
  • Clarissa C Menezes
  • Raymond Jean
  • Natalie V Singer
  • Bruce R Blazar
  • Chen Liu
  • Nancy A Kernan
  • Mallory L West
  • Arnab Ghosh
  • Michele J Equinda
  • Odette M Smith
  • Kazutoshi Aoyama

Detail Information

Publications18

  1. pmc Microbiome mediation of infections in the cancer setting
    Ying Taur
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA
    Genome Med 8:40. 2016
    ....
  2. pmc The intestinal microbiota and susceptibility to infection in immunocompromised patients
    Ying Taur
    Infectious Diseases, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, New York 10065, USA
    Curr Opin Infect Dis 26:332-7. 2013
    ..This article reviews and discusses recent work providing insight into the intestinal microbiota of these at-risk immunocompromised patients...
  3. pmc Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 55:905-14. 2012
    ..We examined the microbiota of patients undergoing allo-HSCT, and correlated microbial shifts with the risk of bacteremia...
  4. pmc Effect of antifungal therapy timing on mortality in cancer patients with candidemia
    Ying Taur
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 9, New York, NY 10065, USA
    Antimicrob Agents Chemother 54:184-90. 2010
    ..Strategies to shorten the incubation time, such as utilizing rapid molecularly based diagnostic methods, may help reduce in-hospital mortality...
  5. pmc The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
    Ying Taur
    Infectious Disease Service, Department of Medicine, and Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY Weill Cornell Medical College, New York, NY
    Blood 124:1174-82. 2014
    ..These results indicate that the intestinal microbiota may be an important factor in the success or failure in allo-HSCT. ..
  6. pmc Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation
    Melissa A Kinnebrew
    Immunology Program, Sloan Kettering Institute, New York, New York, United States of America Weill Cornell Medical College, New York, New York, United States of America
    PLoS ONE 9:e90158. 2014
    ..Further study of this unique population with more discriminating CDI diagnostic tests are warranted. ..
  7. pmc Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
    Robert R Jenq
    Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Exp Med 209:903-11. 2012
    ..Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients...
  8. pmc Role of intestinal microbiota in transplantation outcomes
    Ying Taur
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Weill Cornell Medical College, New York
    Best Pract Res Clin Haematol 28:155-61. 2015
    ..The following paper discusses the most recent developments in this area. ..
  9. pmc Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
    Charlie G Buffie
    1 Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA 2 Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Nature 517:205-8. 2015
    ..These findings have implications for the rational design of targeted antimicrobials as well as microbiome-based diagnostics and therapeutics for individuals at risk of C. difficile infection. ..
  10. pmc Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Immun 81:965-73. 2013
    ..Our studies indicate that obligate anaerobic bacteria belonging to the Barnesiella genus enable clearance of intestinal VRE colonization and may provide novel approaches to prevent the spread of highly antibiotic-resistant bacteria...
  11. pmc Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
    Carles Ubeda
    Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Clin Invest 120:4332-41. 2010
    ..Thus, high-throughput DNA sequencing of the intestinal microbiota could identify patients at high risk of developing bacterial sepsis...
  12. pmc Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center
    Sejal Morjaria
    Infectious Disease Service, Department of Medicine
    Open Forum Infect Dis 3:ofw070. 2016
    ..However, patients with hematologic malignancies not treated with allogeneic HSCT may also develop this condition, which requires high clinical suspicion and consideration for prophylactic therapy. ..
  13. pmc Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
    Robert R Jenq
    Adult BMT, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York Electronic address
    Biol Blood Marrow Transplant 21:1373-83. 2015
    ..We conclude that increased abundance of commensal bacteria belonging to the Blautia genus is associated with reduced lethal GVHD and improved overall survival. ..
  14. pmc Gut microbiota and tacrolimus dosing in kidney transplantation
    John R Lee
    Department of Medicine, Division of Nephrology and Hypertension, Weill Cornell Medical College, New York, New York, United States of America Department of Transplantation Medicine, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, United States of America
    PLoS ONE 10:e0122399. 2015
    ..01) and had a coefficient ± standard error of 1.0 ± 0.6 (P=0.08) after multivariable linear regression. Our novel observations may help further explain inter-individual differences in tacrolimus dosing to achieve therapeutic levels...
  15. doi request reprint International travel patterns and travel risks of patients diagnosed with cancer
    Tarek Mikati
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA
    J Travel Med 20:71-7. 2013
    ..Immunocompromised travelers living with cancer can be at increased risk of travel-related illnesses. Their international travel patterns and associated risks remain largely unknown...
  16. pmc Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant
    Mini Kamboj
    1Infection Control, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
    Infect Control Hosp Epidemiol 37:8-15. 2016
    ..Transmission on stem cell transplant unit was confirmed in 19% of early CDI cases in our cohort with a probable donor source established in half of the cases...
  17. pmc Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
    Simone Becattini
    Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Trends Mol Med 22:458-78. 2016
    ....
  18. pmc Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation
    Michelle B Mahler
    Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Biol Blood Marrow Transplant 18:145-9. 2012
    ..Administration of a 2-dose series, as currently recommended for patients with asplenia, complement deficiency, and HIV infection, should be evaluated in this patient population...